Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
600276.CN | Jiangsu Hengrui Pharmaceuticals Co., Ltd | 63.5 | ¤52,550 | CN |
603259.CN | WuXi AppTec Co., Ltd. Class A | 70.8 | ¤27,262 | CN |
300015.CN | Aier Eye Hospital Group Co., Ltd. Class | 64.0 | ¤15,886 | CN |
002001.CN | Zhejiang NHU Co. Ltd. Class A | 80.2 | ¤9,254 | CN |
000999.CN | China Resources Sanjiu Medical & Pharmac | 59.9 | ¤7,196 | CN |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 60.0 | ¤587 | CN |
688179.CN | Shanghai Aladdin Biochemical Technology | 62.3 | ¤590 | CN |
301277.CN | Newland Pharmaceutical Co., Ltd. Class A | 60.8 | ¤618 | CN |
688581.CN | Hangzhou AGS MedTech Co. Ltd. | 62.1 | ¤715 | CN |
000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 60.8 | ¤1,063 | CN |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
600276.CN | Jiangsu Hengrui Pharmaceuticals Co., Ltd | 63.5 | 22 | CN |
000999.CN | China Resources Sanjiu Medical & Pharmac | 59.9 | 19 | CN |
002001.CN | Zhejiang NHU Co. Ltd. Class A | 80.2 | 19 | CN |
000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 69.5 | 18 | CN |
300015.CN | Aier Eye Hospital Group Co., Ltd. Class | 64.0 | 11 | CN |
600062.CN | China Resources Double-Crane Pharmaceuti | 70.9 | 11 | CN |
000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 60.8 | 10 | CN |
002262.CN | Jiangsu Nhwa Pharmaceutical Co., Ltd. Cl | 67.3 | 10 | CN |
600216.CN | Zhejiang Medicine Co., Ltd. Class A | 62.9 | 9 | CN |
600750.CN | Jiangzhong Pharmaceutical Co., Ltd. Clas | 67.3 | 9 | CN |
Average Market Cap | ¤5,730 |
Median Market Cap | ¤2,012 |
Avg. 3 Mo. Dollar Vol. | ¤51,966,308 |
Avg. 3 Mo. Trading Vol. | 14,437,816 |
Last Rebalance Date | 06/16/2025 |
Companies Replaced | 17 |
Biggest Sector Increase | Health Care |
Biggest Sector Decrease | Health Care |
Trailing P/E Ratio (12 Mo.) | 21.2 |
Forward P/E Ratio (12 Mo.) | 16.2 |
Price/Book Ratio | 3.3 |
Avg. Revenue Chg. - 3 Yr | 41.3% |
Avg. Op. Income Chg. - 3 Yr. | 60.2% |
Avg. EPS Growth - 3 Yr. | 17.2% |
Avg. EPS Growth - 1 Yr. | 17.2% |
Avg. Operating Margin | 24.1% |
Avg. LT Debt to Total Capital | 2.6% |
Avg. Return on Equity | 16.2% |
Dividend Yield | 1.7% |
China Health Care Index | 64.35 |
China | 100.0% |